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ABSTRACT: Fragile X syndrome, the most common cause of inherited mental retardation, is caused by the
absence of the fragile X mental retardation protein (FMRP). The emerging picture is that FMRP is involved
in repression of translation through a complex network of protein-protein and protein-RNA interactions.
Very little structural information is, however, available for FMRP that could help to understand its function.
In particular, no structural studies are available about the N-terminus of the protein, a highly conserved
region which is involved in several molecular interactions. Here, we explore systematically the ability of
the FMRP N-terminus to form independently folded units (domains). We produced deletion mutants and
tested their fold and functional properties by mutually complementary biophysical and biochemical
techniques. On the basis of our data, we conclude that the N-terminus contains a domain, that we named
NDF, comprising the first 134 amino acids. Most interestingly, NDF comprises two copies of a newly
identified Agenet motif. NDF is thermally stable and has a high content of â structure. In addition to
being able to bind to RNA and to recognize some of the FMRP interacting proteins, NDF forms stable
dimers and is able to interact, although weakly, with the full-length protein. Our data provide conclusive
evidence that NDF is a novel motif for protein-protein and protein-RNA interactions and contains a
previously unidentified dimerization site.
Fragile X mental retardation syndrome, the most common
cause of inherited mental retardation in humans, is caused
by pathological expansion of a CGG trinucleotide repeat in
the 5′ untranslated region (5′UTR)1 of the FMR1 gene (for
recent reviews, see refs 1 and 2). As a consequence of the
expansion, the FMR1 locus is usually silenced at the
transcriptional level with consequent absence of the FMR1
gene product, the FMR1 protein (FMRP), in affected
individuals. Although ubiquitous, FMRP is most abundant
in testes and brain, the organs most affected by the syndrome
(3-6). FMRP is a cytoplasmic protein that is also found in
distal dendrites, where its local concentration increases in
response to neurotransmitter activation (7, 8).
The cellular role of FMRP is still mostly unknown, despite
the direct correlation between anomalies in the expression
of the protein and the occurrence of fragile X syndrome.
The current view is that FMRP is a negative regulator of
translation in a manner critical for the development of
neurons (9-12). To achieve this function, FMRP is an RNA-
binding protein that forms an extended network of interac-
tions with several nuclear and cytoplasmic protein partners
(12-16). Several RNAs have been identified in vitro and in
vivo as its potential partners (9, 17-20). Among them, a
small nontranslated RNA, BC1, has been shown to mediate
the interaction of FMRP with specific mRNAs at synapses
(11). FMRP is associated with polyribosomes as a component
of a large mRNP complex which shuttles between polyri-
bosomes and cytoplasmic granules (12, 21, 22). Direct
interactions with the two close paralogues FXR1P and
FXR2P and with the proteins NUFIP1, CYFIP1, and CYFIP2
have also been demonstrated (23-26). FMRP is able to
heterodimerize in vitro with FXR1P and FXR2P (26, 27)
but seems mainly to homodimerize in vivo (28).
FMRP is a medium-size protein (632 residues long)
(Figure 1). Its sequence comprises an N-terminal block of
444 residues (which spans up to the end of exon 14) with a
high degree of conservation within the FMRP family (70-
80% identity and 80-90% similarity) (26). This region
contains two copies of the K-homology (KH) motif preceded
by an N-terminus ca. 220 long. Conversely, no conservation
is observed at the protein C-terminus, where an RGG box,
a motif typically involved in nonspecific RNA recognition,
is observed. Interestingly, many of the interactions so far
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identified have been mapped to the N-terminus (16). This
observation raises several important questions: How does
the N-terminus recognize its partners? Is there any structural
motif that is involved in the interactions? Do all the
interactions compete for the same site by a subtle mechanism
of mutual competition or are there distinct interacting sites?
However, structural information is so far only available for
the first KH module of FMRP (29), and very little is known
about the structure of the FMRP N-terminus.
In this study, we describe the results of an extensive
biochemical and biophysical characterization of the N-
terminus of FMRP with the aim of understanding the role
of this region in the molecular interactions known so far.
We show that the N-terminus contains an independently
folded domain localized in the first 134 residues. This region
is able to bind to RNA as well as to homodimerize and to
interact with other protein partners.
MATERIALS AND METHODS
Sample Preparation. The FMRP constructs used for this
study are FMRP(1-217), FMRP(1-214), FMRP(1-180),
FMRP(1-134), and FMRP(80-160), where the numbers in
parentheses indicate the regions of the FMRP sequence.
FMRP(1-217) was used for all of the biophysical studies,
whereas, for comparison with previous data (30), FMRP-
(1-214) was used for the binding assays. All FMRP
fragments were amplified by PCR with engineered NcoI on
5′ ends and NotI on 3′ ends from the complete cDNA. The
constructs were cloned in a pET9-derived plasmid as fusion
proteins either with a six histidine tag and/or glutathione
S-transferase (GST). All clones were expressed in Escheri-
chia coli BL21(DE3). The cells were grown in LB medium
with either ampicillin (100 mg/L) or kanamycin (30 mg/L),
induced for 3-4 h by addition of 0.5 mM isopropyl â-D-
thiogalactopyranoside (IPTG) when the cultures reached an
optical density of 0.8 at 600 nm. The cells were harvested
(Beckman centrifuge) and resuspended in lysis buffer (20
mM Tris-HCl at pH 8, 200 mM NaCl, 0.2% IGEPAL CA-
630, 2 mM â-mercaptoethanol, lysozyme from Sigma, and
Dnase I and antiproteases from Boehringer Mannheim),
sonicated (Branson sonifier, model 250/450) for 5 min at
amplitude 5, and centrifuged at 18000 rpm for 40 min. The
proteins were purified by affinity chromatography (using Ni-
NTA gel or glutathione-Sepharose). The fusion protein or
the His tag was removed, when necessary, by tobacco etch
virus (TEV) protease. When necessary an additional affinity
chromatography step of purification was performed to
separate GST from the proteins of interest. One further step
of purification was performed by gel filtration chromatog-
raphy using a G75 16/60 column (Pharmacia). The purity
of the recombinant proteins was checked by SDS-PAGE
after each step of purification and by mass spectroscopy of
the final products.
Limited Proteolysis. The proteins were incubated with
trypsin, chymotrypsin, subtilisin, and endoprotease V8 using
enzyme-to-substrate ratios (w/w) ranging from 1:100 to
1:250. The extent of each reaction was monitored by
sampling the reaction mixture at different incubation times.
Proteolytic fragments were fractionated by reverse-phase
HPLC on a Phenomenex Jupiter C18 column (250 mm 
2.1 mm) with a linear gradient from 5% to 60% of
acetonitrile containing 0.1% TFA over 60 min. Mass
spectrometry identification of collected chromatographic
fractions was performed by an API100 electron-spray mass
spectrometer (Applied Biosystems) equipped with a qua-
drupolar analyzer.
Experiments To Probe the Aggregation State of the
Constructs. FPLC gel filtration chromatography was per-
formed using a G-200 10/30 High-Load column. The
concentrations were 32, 7.1, and 35 íM for FMRP(1-217),
FMRP(1-180), and FMRP(1-134), respectively.
Sedimentation equilibrium experiments were carried out
using a Beckman XL-A analytical ultracentrifuge equipped
with UV absorption optics. Protein concentrations of 20 íM
were chosen so that the absorbance at 280 nm was in the
0.2-1.0 range (12 mm path length). The molar extinction
coefficients of the three samples are 27790 cm-1 M-1 for
FMRP(1-217) and FMRP(1-180) and 25100 cm-1 M-1 for
FMRP(1-134). The measurements were carried out at 15
and 25 °C using speeds of 12000 and 16000 rpm for FMRP-
(1-217), 18000 and 22000 rpm for FMRP(1-180), and
16000 and 20000 rpm for FMRP(1-134). Data were
recorded over an interval of 16 h. Each measurement was
repeated after 8 h to ensure that equilibrium had been reached
and that proteolysis was not occurring. In all data sets, the
absorbance of the baseline was obtained by fitting the data
at different speeds. A two-component self-association mech-
anism was assumed to allow for dimerization. The data were
analyzed with the Origin XL-A/XL1 package (Beckman).
Light scattering experiments were performed on a lumi-
nescent spectrometer. Measurements were carried out at 20
°C on 200 íL samples using 50, 70, and 200 íM protein
concentrations, in 20 mM Tris-HCl at pH 8, in a 1 cm path-
length fluorescence cuvette with excitation and emission
wavelengths of 780 nm. The protein solutions were filtered
with a 0.02 íM cutoff filter prior to the measurements. UV
spectra in the range 250-450 nm were also recorded to
follow aggregation. Temperature-dependent measurements
were performed in the range 20-70 °C using 11 íM samples.
Once at 70 °C, reversibility was tested by lowering the
temperature and recording a spectrum at 20 °C.
Experiments To Probe the Secondary and Tertiary Struc-
ture of the Constructs. Circular dichroism (CD) spectra were
recorded on a Jasco J-715 spectropolarimeter equipped with
a thermostatically controlled cell holder stabilized by circu-
lating water from a Neslab RTE-110 water bath. Rectangular
quartz cuvettes (Hellma) with 0.01 and 0.1 cm path lengths
were used. Ten scans were averaged, and an appropriate
buffer baseline was subtracted. The spectra were recorded
in 20 mM Tris-HCl at pH 8 using protein concentrations of
FIGURE 1: Schematic representation of FMRP showing the sequence
motifs and their position along the sequence. NLS and NES stand
for nuclear localization signal and nuclear export signal, respec-
tively.
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6 and 100 íM. Temperature-dependent unfolding and re-
folding were followed in the 20-75 °C range by monitoring
CD at 222 nm using a heating rate of 1 °C/min.
Nuclear magnetic resonance (NMR) experiments were
performed on a Varian Unity 600 MHz spectrometer
equipped with z-shielded gradient coils using 0.1-0.5 mM
samples in 20 mM Tris-HCl at pH 8 to which 10% D2O
volume had been added. The experiments were performed
at 27 °C.
Experiments To Probe the Functions of FMRP N-Terminal
Fragments. Full-length GST-FMRP fusion protein (1 íg)
produced in insect cells (23) was mixed with 3 íg of His-
tagged FMRP(1-214), FMRP(1-180), and FMRP(1-134)
produced in E. coli and with 20 íL of GST beads (Amer-
sham). The assay was carried out in PBS at pH 7.4 and 0.5%
Triton X-100 (binding buffer) at 4 °C overnight. As a
negative control, the fragments were also tested with the GST
beads alone. The beads were centrifuged at 2000 rpm for 2
min, washed four times with 600 íL of binding buffer, and
finally resuspended in 10 íL of Laemmli sample buffer. The
binding was probed by a murine monoclonal antibody raised
against the FMRP N-terminus.
RNA binding to homopolymers was probed by following
the assay described (31) with minor modifications. GST was
used as a negative control. Five-tenth milliliter of 10 íg
solutions of the purified proteins in the binding buffer (10
mM Tris-HCl at pH 7.4, 2.5 mM MgCl2, 0.5% Triton, 150
or 500 mM NaCl) was individually mixed with agarose-
bound poly(rA), poly(rU), poly(rG), and poly(rC) beads
(purchased from either Sigma or Amersham) (50 íL of fully
swollen matrix in the binding buffer). The mixture was left
to incubate for 4 h at 4 °C. The beads were pelleted with a
short spin in a microfuge and washed four times with 600
íL of binding buffer prior to resuspension in SDS-PAGE
loading buffer. Bound proteins were eluted from nucleic acid
by boiling and redissolved in an SDS-PAGE. The proteins
were transferred to PDVF membrane (Amersham) and
visualized by immunoblot. Filters were processed according
to instructions from the manufacturer. Either a murine
monoclonal antibody raised against the FMRP N-terminus
or a monoclonal anti-6-His tag antibody was used for
detection. The assay was repeated four times to check for
reproducibility. To increase the sensitivity, the RNA-binding
assay described here differs from that described in Adinolfi
et al. (30) in the amount of RNA beads, the protein
concentrations, and the incubation time (20 íL of RNA
beads, 3 íg of protein concentration, and 20 min, respec-
tively).
RESULTS
FMRP(1-217) Is Not the Minimal Unit Able To Retain a
3D Fold. The FMRP(1-217) construct contains the first
seven exons of the FMR1 gene and directly precedes the
first KH repeat. A preliminary study by CD of a slightly
shorter construct [FMRP(1-214)] had shown that this region
has some secondary structure and a high tendency to
aggregate (30). Different biophysical techniques were used
to characterize further the state of aggregation of FMRP-
(1-217). The molecular mass of FMRP(1-217) as calcu-
lated from analytical ultracentrifugation measurements is 34
kDa (at 20 íM protein concentration), which is between that
expected for the monomeric (25 kDa) and the dimeric (50
kDa) species. Measurements were carried out at both low
(10 mM) and high salt (150 mM) concentrations. A good fit
to the data could be obtained only at low salt by assuming
a monomer/dimer equilibrium with ca. 60% of the dimeric
form (Figure 2a). This is consistent with a dissociation
constant in the micromolar range. Studies at higher concen-
trations with this technique were prevented by the high molar
FIGURE 2: (a) Sedimentation equilibrium data of FMRP(1-217)
at 16000 rpm and 20 °C. (b) Calibration curve for apparent
molecular mass determination of FMRP(1-217), FMRP(1-180),
and FMRP(1-134) in native condition by gel filtration chroma-
tography. Bovine serum albumin, 67 kDa (A), carbonic anhydrase,
29 kDa (B), and cytochrome c, 12.4 kDa (C), were used as
molecular mass standards. (c) UV spectra of 11 íM samples of
FMRP(1-217) recorded at increasing temperatures in the range
20-80 °C.
S/F Relationship of an N-Terminal Domain of FMRP Biochemistry, Vol. 42, No. 35, 2003 10439
extinction coefficient of FMRP(1-217) (27790 cm-1 M-1).
More qualitative techniques, such as analytical gel filtration
and light scattering, had thus to be used.
At 30 íM protein concentration, the apparent molecular
mass of FMRP(1-217) as estimated by analytical gel
filtration chromatography was 56 kDa, a value compatible
with that expected for a dimeric species (Figure 2b). No peak
corresponding to the monomer was detected. Light scattering
experiments were performed at two different concentrations
(70 and 200 íM). When the FMRP(1-217) solutions were
passed through a 0.02 ím cutoff filter before each measure-
ment, the filter was readily blocked, preventing the measure-
ments and suggesting the presence of high molecular mass
species (data not shown). Similarly, ultraviolet (UV) spectra
in the 250-450 nm range did not show a stable baseline, a
phenomenon characteristic of polydisperse samples. An
increase in light scattering was observed as the temperature
was increased, indicating formation of large aggregates. The
process was irreversible upon cooling (Figure 2c).
In summary, the N-terminus of FMRP contains secondary
structure elements and exists in solution in a dimeric form.
However, it has a strong tendency to further aggregate
unspecifically at high concentrations.
FMRP(1-134) Forms a Specific Dimer. To find the
smallest region able to retain a three-dimensional structure
with no or little tendency to nonspecific aggregation, limited
proteolysis was carried out on FMRP(1-217) (data not
shown). Protease protection was observed for residues 80-
160, suggesting the presence of a folded species in this
region. A construct spanning residues from 80 to 160 was
cloned and expressed but was insoluble and led to the
formation of inclusion bodies even when different temper-
ature conditions were tested.
We then explored systematically the properties of two
fragments designed using both the exon-intron boundaries
and the residue conservation: one spanning region 1-134
[FMRP(1-134)] and the second comprising residues 1-180
[FMRP(1-180)] (Figure 3). Both regions comprise either
part or all of the proteolysis-protected region but terminate
at the end of predicted secondary structure elements. In
particular, a potential helix-loop-helix motif is predicted
between amino acids 180-222. If this prediction were
correct, this region could be involved in self-association of
FMRP(1-217) since helix-loop-helix motifs are often
responsible for dimerization (32). The two constructs were
cloned and expressed, purified, and structurally characterized.
The state of aggregation of FMRP(1-180) and FMRP-
(1-134) was checked as for FMRP(1-217). Analytical
ultracentrifugation measurements of 20 íM samples led to
molecular masses of 44 and 33 kDa to be compared with
the expected masses of the dimeric forms (45.6 and 31.4
kDa, respectively) (Figure 4a). Good curve fitting was
achieved for both constructs by assuming a pure dimeric
state, consistent with a dissociation constant in the nanomolar
range. Accordingly, the apparent molecular masses of FMRP-
(1-180) (7.5 íM) and FMRP(1-134) (36 íM) as estimated
by gel filtration were 43.9 and 33.4 kDa, respectively. Light
scattering and UV spectra of FMRP(1-180) have a behavior
similar to those of FMRP(1-217). FMRP(1-134), on the
other hand, presented a stable baseline and no blockage of
the filter, indicating a monodisperse sample with a calculated
mass of 39 kDa (data not shown). These results show that
the N-terminal 134 residues of FMRP are sufficient for
homodimerization. C-Terminal extension of this region seems
to promote nonspecific interactions that lead to aggregation.
To probe whether FMRP(1-134) is able to bind the full-
length FMRP, interactions between the bacterially produced
FMRP(1-134), FMRP(1-180), and FMRP(1-214) and the
GST fusion full-length FMRP (23) were tested together in
pull-down experiments. The three fragments were all able
to interact with FMRP although with affinities decreasing
with the length of the construct (Figure 4b).
FMRP(1-134) Folds into a Domain with Significant â
Structure Content. The secondary and tertiary structures of
the constructs were probed by CD and NMR. The far-UV
CD spectra of FMRP(1-180) and FMRP(1-134) are shown
in Figure 5a and compared with the spectra of FMRP(1-
217). All three constructs have a minimum at 208 nm which
is deeper in the two longer constructs. The spectra of FMRP-
(1-180) and FMRP(1-217) have very similar features,
whereas that of FMRP(1-134) has a pronounced maximum
at 230 nm, most likely arising from the contribution of
aromatic side chains. An estimate of the secondary structure
content by curve fitting suggests a minor helical content
FIGURE 3: Multiple alignments of the N-terminal region of the FMR family, color-coded to highlight similarities (39). All G (orange) and
P (yellow) residues are colored. Other coloring is by a conserved property in more than 40% (or more than 30% for K, R, and H) of a
column according to the following convention: blue, hydrophobic; light blue, partially hydrophobic; red and pink, positive; purple, negative;
green, hydrophilic. The sequence numbering (ruler) is displayed according to the FMR1_HUMAN sequence. Secondary structure predictions
were made on the multiple aligned FMRP sequences using the PHD web server (40) and displayed in the first line.
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(below or around 5%) with an approximately equal content
of â and random structure (40-45%).
A 1D NMR 1H spectrum of FMRP(1-134) was recorded
and compared with those of the two longer constructs (Figure
5b). The spectrum of FMRP(1-134) shows a good resonance
dispersion typical of a well-defined tertiary fold, as supported
by the presence of resonances in the range from -1 to 0.8
ppm: these arise from aliphatic protons in proximity of
aromatic rings which, when locked into a defined conforma-
tion, generate an additional local magnetic field. The 1D 1H
spectra of FMRP(1-180) and FMRP(1-217) are progres-
sively broader, indicating a polydisperse state of these
constructs at NMR concentrations (millimolar range). Reso-
nances around 5 ppm in the spectrum of FMRP(1-134)
[visible also in the spectrum of FMRP(1-180) but presum-
ably too broad to be visible in FMRP(1-217)] are suggestive
of an appreciable â content.
The thermal stability of the three constructs was deter-
mined by thermal denaturation followed by monitoring the
ellipticity at 222 nm in the CD spectra. Two different
concentrations (6 and 100 íM) were used for each construct.
The melting point is comparable for FMRP(1-217) and
FMRP(1-180) (57.6 ( 0.3 and 57.4 ( 0.2 °C, respectively)
and lower for FMRP(1-134) (52.1 ( 0.2 °C). Interestingly,
at low concentration, a conformational transition was ob-
served at high temperature, with the signal becoming
progressively more negative (Figure 5a). Comparison of the
spectra at 25 °C and at 80 °C shows that the shallow
minimum observed at 208 nm at room temperature shifts
toward 215 nm and becomes deeper. At 80 °C the CD
spectrum presents a single well-defined minimum at 215 nm,
typical of a â-sheet conformation. When the same experiment
was performed at 100 íM, the FMRP(1-217) solution turned
opalescent around 40 °C, suggesting aggregate formation,
which impaired complete data collection at this concentration.
In all cases the process is cooperative but irreversible (Figure
5c). These results are consistent with a conformational
transition occurring at high temperatures in which an
intermolecular â conformation is stabilized, similar to that
observed for â-amyloid formation (33). However, a prelimi-
nary check of the nature of the precipitate by electron
microscopy (EM) showed only amorphous precipitation (data
not shown).
Probing the RNA-Binding Properties of the Three Con-
structs. We have previously demonstrated that the FMRP
N-terminus is able to recognize RNA homopolymers (30).
We tested if also the shorter constructs retain RNA binding.
Binding was tested using the four homopolymers im-
mobilized on agarose beads. All constructs are able to bind
the homopolymers when 150 mM NaCl concentration was
used, although the signal is very weak for some homonucle-
otides (Figure 6). The constructs seem to have different
specificity: FMRP(1-180) and FMRP(1-134) have the
highest affinity for poly(rU) and the lowest for poly(rG).
These results should be compared with those obtained for
FMRP(1-214) [as described by Adinolfi et al. (30) and
repeated here for consistency] which has clear preference
for poly(rG) and poly(rU). At higher salt concentrations (500
mM NaCl), binding was retained, although generally weaker,
by most of the constructs (data not shown). No signal was
detected when the constructs were tested under the same
conditions without the agarose beads and when His-tagged
glutathione S-transferase (GST), a protein with no RNA-
binding properties, was used as a negative control.
DISCUSSION
We have reported here a structural and functional char-
acterization of the FMRP N-terminus, a region strongly
conserved through evolution and known to be involved in
several molecular interactions (16). We show that region
1-134 (which covers the first five exons) forms an inde-
pendently folded unit, which we named NDF, for N-terminal
domain of FMRP. While we were in the process of
submitting the present paper, Ponting and co-workers
reported detectable although low sequence homology be-
tween regions 3-43 and 62-108 of FMRP and the Tudor
domain family, which also comprises the Chromo and MBT
domains as well as a new plant-specific Agenet domain (34).
This similarity would then place FMRP into a larger family
of proteins that has evolved from a common ancestor with
methyl substrate binding functions. The prediction is fully
supported by our data since the expected fold for these
regions would be predominantly â, as we observe by CD.
FIGURE 4: (a) Sedimentation equilibrium data of FMRP(1-134)
at 16000 rpm and 25 °C. (b) GST pull-down assay to probe
interaction of the fragments with full-length FMRP. GST fusion
FMRP was mixed with 3 íg of FMRP(1-134), FMRP(1-180),
and FMRP(1-214) (lanes 4-6, respectively). As a negative control,
3 íg of the fragments was mixed with glutathione-Sepharose (lanes
1-3). This assay was carried out in phosphate-buffered saline (PBS)
(Pharmacia) and 0.5% Triton X-100.
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Definition of a new structural domain in FMRP, in addition
to the two KH motifs, is very important to revisit and
interpret the functional data available. NDF is able to retain
several of the functions mapped on the FMRP N-terminus.
FMRP(1-134) recognizes RNA as it does the longer FMRP-
(1-214) (30). Consistently, conserved positively charged
residues which could contribute to RNA binding are present
along the whole length of the N-terminus (Figure 3).
However, the affinities to homopolymers progressively
decrease with the length of the constructs, and the three
proteins have different sequence specificities for the ho-
mopolymers. These findings suggest that the contribution
of different binding sites distributed along the N-terminus
is likely to be cooperative.
Many of the FMRP interacting proteins have been identi-
fied by two-hybrid screening using the protein N-terminus
[construct FMRP(1-218)] as a bait. Further mapping was
obtained by GST pull-down using deletion mutants designed,
in the absence of structural indications, according to the exon
boundaries. These do not, however, usually correlate with
the domain definition especially in intracellular proteins, thus
leading to the possibility that a negative result could be
caused not by the absence of a region directly involved in
the interaction but to loss of a region structurally essential.
To demonstrate the power of a structural approach, a
construct spanning NDF has been recently used to map the
interacting region with NUFIP1 and the newly identified 82-
FIP (35): NDF was shown to be sufficient to bind.
The folded NDF is also able to form stable and specific
dimers and to bind, although weakly, full-length FMRP. A
dimerization motif in FMRP(1-134) is somewhat unex-
pected since previous reports had excluded participation of
the region N-terminal to exon 7 into dimerization and
recognition of the close homologues FXR1 and FXR2 (26,
27). However, the discrepancy can be explained by taking
into account that the assays presented here were carried on
FIGURE 5: (a) Comparison of the far-UV CD spectra of the three constructs at 25 °C (open symbols) and 80 °C (gray symbols). The
concentrations used to record these spectra are 100 íM. Triangles, squares, and circles are used for FMRP(1-134), FMRP(1-180), and
FMRP(1-217), respectively. (b) Comparison of the 1D NMR spectra of FMRP(1-217) (top), FMRP(1-180) (middle), and FMRP(1-
134) (bottom). The spectra were recorded at 25 °C and 600 MHz on samples around 0.2 mM concentration. The sharp peaks at 3.5 ppm
are from the buffer. The peak at 4.7 ppm is residual water. (c) Thermal denaturation curves recorded for the three samples following the
signal at 222 nm. The same convention as in panel a is used.
FIGURE 6: RNA-binding assays using homopolymers p(rA), p(rU), p(rG), and p(rC) immobilized on agarose beads. The constructs are
reported as follows: FMRP(1-214) (lane 1), FMRP(1-180) (lane 2), and FMRP(1-134) (lane 3) performed at pH 7.4 and 150 mM NaCl
as described in Materials and Methods.
10442 Biochemistry, Vol. 42, No. 35, 2003 Adinolfi et al.
highly purified untagged proteins excluding the possibility
of interferences. Also, the relatively low affinity by which
FMRP(1-134) binds with the full-length FMRP makes it
possible to miss this interaction site with methods less
sensitive than the ones used in this study.
It remains possible that, together with NDF, other dimer-
ization sites can cooperatively determine the dimer stability
of the full-length protein. A putative coiled coil, identified
in exon 7, has been proposed to be the main dimerization
motif (27). Also, in our hands, region 181-217 has a strong
tendency to form aggregates of hydrophobic nature. How-
ever, a closer analysis of the exon 7 sequence shows that
this region has a clear helical periodicity but does not contain
heptamotifs that could stabilize a coiled coil (36). Secondary
structure predictions based on a multiple alignment would
rather suggest that this region folds as a helix-loop-helix
motif (Figure 3). Dimerization could occur through pairing
two such motifs, leading to formation of a four-helix bundle.
In the full-length protein, this region could pack either against
other proteins or against distal regions of FMRP, thus
masking additional exposed hydrophobic patches that cause
further aggregation in our FMRP(1-217) construct. A
plausible partner could be KH2, another region suggested
to be implicated in dimerization. A mutant carrying an
FMRP(I304N) point mutation in KH2 was shown to be
unable to self-assemble and, consequently, to bind to
polysomes and inhibit translation (10, 37). However, because
of the important structural role that the semiburied Ile304
plays in the fold of the KH domain (38), it is unlikely that
this residue is directly involved in dimerization. The mutation
should lead to disruption of the KH2 fold, thus altering the
shape of the full-length protein and preventing dimerization.
It is tempting to speculate that the tertiary structure of the
full-length protein brings close together exon 7 and KH2,
which could pack against each other (Figure 7). This
hypothesis could explain the difficulties encountered in
producing isolated recombinant KH2 in a folded form (30).
In conclusion, our results show that the region preceding
the first KH domain contains a newly identified domain able
to bind RNA and to function as a protein-protein interaction
motif. Identification of another autonomously three-dimen-
sional folding unit in FMRP that is able to retain some of
the functions of the full-length protein opens new possibilities
to investigating at atomic details the way FMRP recognize
specific RNA targets and to understanding the essential role
played by the N-terminus in molecular recognition. Further
characterization of the structure of the NDF is currently in
progress in our laboratory.
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